These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y. Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288 [Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Arevalo JF, Sánchez JG, Wu L, Berrocal MH, Alezzandrini AA, Restrepo N, Maia M, Farah ME, Brito M, Díaz-Llopis M, Rodríguez FJ, Reategui G, Iturralde-Iraola J, Udaondo-Mirete P, Pan-American Collaborative Retina Study Group. Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989 [Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab in inflammatory ocular neovascularization. Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M. Am J Ophthalmol; 2008 Sep; 146(3):410-416. PubMed ID: 18619571 [Abstract] [Full Text] [Related]